Pablo Alfonso Carriquiry-Chequer

Dr. Pablo Alfonso Carriquiry-Chequer

Facultad de Medicina, Universidad Autónoma de Nuevo León., Monterrey, Nuevo León, Mexico

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2022 in Life
Verified
Journal Article
Open access
PDF file
JRJorge A Roacho-Pérez
Jorge A Roacho-Pérez
EGElsa Garza-Treviño
Elsa Garza-Treviño
NMNIDIA KARINA MONCADA-SAUCEDO
NIDIA KARINA MONCADA-SAUCEDO
PCPablo Alfonso Carriquiry-Chequer
Pablo Alfonso Carriquiry-Chequer
LVLaura Elizabeth Valencia-Gomez
Laura Elizabeth Valencia-Gomez
JIJose Francisco Islas
Jose Francisco Islas
Cardiovascular diseases are a leading cause of death worldwide. Current treatments directed at heart repair have several disadvantages, such as a lack of donors for heart transplantation or non-bioactive inert materials for replacing damaged tissue. Because of the natural lack of regeneration of cardiomyocytes, new treatment strategies involve stimulating heart tissue regeneration. The basic three elements of cardiac tissue engineering (cells, growth factors, and scaffolds) are described in this review, with a highlight on the role of artificial scaffolds. Scaffolds for cardiac tissue engineering are tridimensional porous structures that imitate the extracellular heart matrix, with the ability to promote cell adhesion, migration, differentiation, and proliferation. In the heart, there is an important requirement to provide scaffold cellular attachment, but scaffolds also need to permit mechanical contractility and electrical conductivity. For researchers working in cardiac tissue engineering, there is an important need to choose an adequate artificial scaffold biofabrication technique, as well as the ideal biocompatible biodegradable biomaterial for scaffold construction. Finally, there are many suitable options for researchers to obtain scaffolds that promote cell–electrical interactions and tissue repair, reaching the goal of cardiac tissue engineering.

23 March 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
JRJorge A Roacho-Pérez
Jorge A Roacho-Pérez
EGElsa Garza-Treviño
Elsa Garza-Treviño
NMNIDIA KARINA MONCADA-SAUCEDO
NIDIA KARINA MONCADA-SAUCEDO
PCPablo Alfonso Carriquiry-Chequer
Pablo Alfonso Carriquiry-Chequer
LVLaura Elizabeth Valencia-Gomez
Laura Elizabeth Valencia-Gomez
JIJose Francisco Islas
Jose Francisco Islas
Cardiovascular diseases are the leading cause of death worldwide. Cardiovascular diseases complication can give rise to myocardial infarction which produces cell death by blockage of blood flow, leading to loss of heart function. Current treatments directed at heart repair have several disadvantages such as the lack of donors for heart transplantation or the use of non-bioactive inert materials for replacement of the damage tissue. New treatment strategies involve stimulation of heart tissue regeneration with the use of bioactive materials like chitosan, in combination with cells and biochemical factors. Chitosan scaffolds have the necessary proprieties of biocompatibility, porosity, and biodegradation, that imitates the heart extracellular matrix. Chitosan scaffolds physical proprieties, such as electrical conductivity and mechanical proprieties, can be improved by different preparation techniques and by the functionalization with other materials.